Related Experiment Video
Updated: Apr 6, 2026
07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.8K
Surface-Enhanced Raman Spectroscopy: A New Modality for Cancer Imaging
Chrysafis Andreou1, Sirish A Kishore1, Moritz F Kircher2
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Summary
Surface-enhanced Raman scattering (SERS) imaging is a novel in vivo cancer detection tool. Biocompatible SERS nanoprobes offer superior sensitivity, specificity, and multiplexing for medical imaging applications.
Area of Science:
- Biomedical Engineering
- Molecular Imaging
- Nanotechnology
Background:
- Surface-enhanced Raman scattering (SERS) spectroscopy, traditionally an in vitro tool, is emerging for in vivo applications.
- Recent advancements demonstrate the feasibility of using biocompatible SERS probes for in vivo cancer imaging.
Purpose of the Study:
- To review the principles of SERS spectroscopy.
- To highlight recent advances in SERS for in vivo cancer imaging.
- To assess the potential of SERS in medical imaging.
Main Methods:
- Review of existing literature on SERS principles and applications.
- Focus on studies utilizing biocompatible SERS nanoprobes for in vivo cancer imaging.
- Inclusion of studies with histological correlation to validate imaging data.
Main Results:
- SERS imaging offers significant advantages over other molecular imaging methods.
- SERS nanoprobes provide higher sensitivity and signal specificity.
- SERS technology enables multiplexing capabilities for advanced applications.
Conclusions:
- SERS imaging holds great potential for revolutionizing medical diagnostics, particularly in oncology.
- Biocompatible SERS nanoprobes represent a promising advancement for in vivo molecular imaging.
- Further research and validation are crucial for clinical translation of SERS cancer imaging.
